2017
DOI: 10.1016/j.vaccine.2016.12.001
|View full text |Cite
|
Sign up to set email alerts
|

Moving beyond traditional valuation of vaccination: Needs and opportunities

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
49
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
7
3

Relationship

1
9

Authors

Journals

citations
Cited by 63 publications
(52 citation statements)
references
References 15 publications
0
49
0
Order By: Relevance
“…35 Vaccines could prevent infectionseither sensitive or resistantand also reduce the use of antimicrobials, which in turn could slow the growth of AMR. [36][37][38][39][40][41][42][43][44][45][46] Child development benefits of vaccines Persistent or recurrent infections in early life can lead to poor growth and stunting, which in turn can adversely affect adult health, cognitive capacity, and economic productivity. [47][48][49] The theoretical basis of the long-term benefits of vaccines is anchored in the widely accepted "fetal origins" hypothesis 50,51 which links conditions in utero and during early childhood with later life outcomes.…”
Section: Economic Equity and Global Health Benefits Of Vaccinesmentioning
confidence: 99%
“…35 Vaccines could prevent infectionseither sensitive or resistantand also reduce the use of antimicrobials, which in turn could slow the growth of AMR. [36][37][38][39][40][41][42][43][44][45][46] Child development benefits of vaccines Persistent or recurrent infections in early life can lead to poor growth and stunting, which in turn can adversely affect adult health, cognitive capacity, and economic productivity. [47][48][49] The theoretical basis of the long-term benefits of vaccines is anchored in the widely accepted "fetal origins" hypothesis 50,51 which links conditions in utero and during early childhood with later life outcomes.…”
Section: Economic Equity and Global Health Benefits Of Vaccinesmentioning
confidence: 99%
“…Several economists have instead proposed the use of cost-benefit analysis (CBA) [7, 8]. The term CBA is often informally used to refer to any analysis used in decision-making that compares the expected costs and benefits (both in monetary terms) of an investment.…”
Section: Introductionmentioning
confidence: 99%
“…This is specifically applicable to vaccination decisions. For example, the decision to be vaccinated against seasonal influenza weighs perception of individual risk of disease against the direct costs of the vaccination, the indirect costs of the time necessary to be vaccinated (lost opportunity), and any concerns about adverse vaccination effects [1] . The implications of individual vaccination in contributing to population immunity further complicates the decision.…”
Section: Introductionmentioning
confidence: 99%